72 results on '"Piano, Salvatore"'
Search Results
2. Infections in cirrhosis
3. Infectious Complications of Portal Hypertension
4. Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting
5. Hepatorenal Syndrome in Cirrhosis
6. A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis
7. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
8. Impact of bacterial infections prior to liver transplantation on post-transplant outcomes in patients with cirrhosis
9. Bacterial Infections in Acute on Chronic Liver Failure
10. Liver transplantation in the patient with physical frailty
11. Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences
12. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
13. Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis
14. Italian association for the study of the liver position statement on SARS-CoV2 vaccination
15. Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation?
16. An Integrated Review of the Hepatorenal Syndrome
17. Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis
18. Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort
19. Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure
20. Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
21. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
22. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe
23. Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome
24. OP-4 DEVELOPMENT AND EXTERNAL VALIDATION OF A MODEL TO PREDICT MULTI-DRUG RESISTANT BACTERIAL INFECTIONS IN PATIENTS WITH CIRRHOSIS
25. O-13 SUB-OPTIMAL GLOBAL PUBLIC HEALTH POLICIES AND STRATEGIES TO TACKLE HEPATOCELLULAR CARCINOMA
26. Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure
27. Intravenous albumin in cirrhosis: Updated clinical uses and novel perspectives
28. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference
29. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)
30. SAT-129 - Sub-optimal global public health policies and strategies to combat hepatocellular carcinoma
31. Recent Advances in the Management of Hepatorenal Syndrome: A US Perspective
32. THU-420 Evaluation of LiverRisk score as predictor of liver fibrosis and mortality in patients with HCV-related hepatitis treated with direct acting antivirals
33. FRI-171 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
34. TOP-241-YI Longitudinal changes in liver stiffness measurements in a population-based screening cohort of 5, 517 participants
35. SAT-083-YI Changes in mean arterial pressure are inadequate to guide treatment with terlipressin and albumin in patients with hepatorenal syndrome-acute kidney injury
36. FRI-101-YI Rectus femoris cross sectional area predicts 90-day readmission in patients hospitalized for an acute decompensation of cirrhosis
37. FRI-078-YI Long-term albumin administration in outpatients with decompensated cirrhosis and diabetes mellitus: post-hoc analysis of the ANSWER trial database
38. FRI-068 Predictors of clinical trajectories in patients surviving an acute decompensation of cirrhosis
39. FRI-047-YI Predictors of ascites resolution in patients with cirrhosis receiving long-term albumin treatment. Results from a real-world study in Italy (Real-ANSWER)
40. TOP-064-YI Impact of bacterial infections on kidney function and survival in patients with decompensated cirrhosis and acute kidney injury worldwide-analysis of the ICA-GLOBAL AKI study
41. TOP-062 Global epidemiology of acute kidney injury in hospitalized patients with cirrhosis: the ICA-GLOBAL AKI study
42. WED-098-YI Low-density lipoprotein can predict hospital readmissions and outcomes following acute decompensation of cirrhosis
43. THU-057-YI Distinguishing clinical profiles in acute-on-chronic liver failure: a comparative analysis of alcohol-related hepatitis versus infection precipitated acute-on-chronic liver failure
44. THU-050 Urinary biomarkers of tubular and glomerular damage predict renal recovery in patients with hepatorenal syndrome-acute kidney injury
45. OS-038-YI Real-world practice patterns on the use of terlipressin in patients with cirrhosis and acute kidney injury-results from the ICA-GLOBAL AKI study
46. OS-035-YI Validating and expanding Baveno VII criteria of recompensation in patients with decompensated cirrhosis
47. O-9 COMPARISON OF THE PERFORMANCE OF DIFFERENT SCORES FOR THE PREDICTION OF IN-HOSPITAL MORTALITY IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTIONS
48. Effects of a reorganization of cirrhosis care during the lockdown for SARS-CoV-2 outbreak
49. WED-343 - Serum PDL1 levels are associated with increased risk of bacterial infections in non-hospitalised patients with cirrhosis
50. WED-348 - Development and external validation of a model to predict multi-drug resistant bacterial infections in patients with cirrhosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.